Fundz

Mirae secures $5.4M in funding led by Oxford Science Enterprises to expand access to world-class specialty care for autoimmune disease treatment.

PRIVATEJul 28, 2026

Amount Raised

$5.4 Million

Round Type

Venture

New YorkBiotechnologyHealth CareArtificial IntelligenceMedical

Investors

Oxford Science Enterprises

Description

Mirae announced $5.4 million in funding, which will help the company enhance its AI-driven continuous care platform for complex chronic conditions. The funding is aimed at improving patient support with a structured view of disease management. Focused on inflammatory bowel disease, Mirae's platform leverages real-world data for better treatment decisions. The investment will facilitate ongoing model development and validation within a leading U.S

Quick answer

Mirae raised $5.4 Million in a funding round, dated July 28, 2026. Investors: Oxford Science Enterprises. Mirae is based in New York, New York, United States.

How much did Mirae raise?
Mirae raised $5.4 Million in a funding round on July 28, 2026.
Who invested in Mirae?
Oxford Science Enterprises is named as investors in this round.
What does Mirae do?
Mirae is an AI-driven continuous care platform focused on autoimmune disease and complex chronic conditions.
Where is Mirae based and how big is it?
Mirae is based in New York, New York, United States.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Mirae that raised within 45 days of this round, from Fundz verified event records.

  • Positron raised $875M (Series C) on September 10, 2026.
  • Epsilon Health raised $28M on September 10, 2026.
  • Hi Rasmus raised $50M on September 6, 2026.
  • Clementine raised $2M (Seed) on August 28, 2026.
  • LymeLess Health raised an undisclosed amount (Seed) on August 22, 2026.
  • Odysight.ai raised $11M (Post-IPO Equity) on August 21, 2026.

Who to call at Mirae, and when

A new round usually means Mirae is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mirae raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mirae, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mirae. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mirae

Location

New York, New York, United States

About

Mirae is an AI-driven continuous care platform focused on autoimmune disease and complex chronic conditions. The platform captures patient experiences between visits and converts them into actionable insights that clinicians can use for informed treatment decisions. Initially targeting inflammatory bowel disease (IBD), Mirae aims to provide ongoing access to real-world patient data to enhance care. By combining patient-reported data with clinical context, the company aspires to improve outcomes and access to world-class care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mirae raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mirae's next move

See what Strategic adds

Mirae raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.